㰀栀琀洀氀㸀
㰀氀椀渀欀 爀攀氀㴀∀猀琀礀氀攀猀栀攀攀琀∀ 琀礀瀀攀㴀∀琀攀砀琀⼀挀猀猀∀ 栀爀攀昀㴀∀猀琀礀氀攀⸀挀猀猀∀⼀㸀
㰀戀漀搀礀㸀
Centre de Référence des Rhumatismes Inflammatoires et Maladies Autoimmunes Systémiques Rares de l’Enfant (RAISE) / 2017
60
Rapport
de
l’OMS-Europe,
publié
Education
Programmes
traduit
en français en 1998.
Recommandations de la Société
Française
de
polyarthrite
Gaujoux-Vial
rhumatoïde.
C,
Gossec
du
Rhumatisme 81 (2014) 303-312.
Épidémiologie et présentation
clinique
Behrens
EM,
Beukelman
T,
Gallo L, Spangler J, Rosenkranz
M,
Arkachaisri
T,
et
al.
Evaluation of the presentation of
systemic
onset
the
Pennsylvania
Systemic
Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008 Feb;35(2):343–8.
Saurenmann
RK,
Rose
RM,
et
idiopathic
in
a
multiethnic cohort: ethnicity as a
risk
Arthritis
Rheum.
2007 Jun;56(6):1974–84.
Évaluation des traitements
Filocamo
Sztajnbok
F,
A,
et
al.
Development
simple
measure
of
arthritis.
Arthritis
Rheum.
2007 Aug 15;57(6):913–20.
Gartlehner
KN.
Biologics
for
treatment
idiopathic
of
arthritis:
a
systematic review and critical analysis of the evidence. Clin
Rheumatol.
Jan;27(1):67–76.
2008
Lurati
B,
Desiati
Gattinara comparison criteria therapeutic patients idiopathic
Gerloni
et
response
in
juvenile treated
and/or
factor
Arthritis 2006
with
arthritis
methotrexate
with
anti-tumor
alpha
Rheum.
May;54(5):1602–7.
Palmisani E, Solari N, Magni-
Manzoni
E,
Panigada
S,
et
juvenile
idiopathic arthritis activity and damage
disease.
Arthritis
Rheum.
2006 Dec 15;55(6):843–9.
Pouchot
Lemelle
Validation
of
the
Health
Questionnaire
Assessment
(CHAQ)
Joint
Bone
2002
Wallace
CA,
Ruperto
N,